U.S. HIV Drug Firm Koronis Pharmaceuticals, Inc. Looks to London Listing

LONDON, March 13 (Reuters) - Koronis Pharmaceuticals, a privately held U .S. biotech firm working on a new kind of HIV drug, is looking to list in London later this year or early in 2012, its chief executive said.